The Diagnostic and Prognostic Potential of Serum Taurine and PUMA in Staging Colorectal Cancer Patients

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Elashry M.A.; Samir S.; Elrefaiy M.; Hammam O.; Abu Taleb H.; Ossama Y.; Elmeligy H.A.

Journal: Recent Patents on Biotechnology

Publisher: Bentham Science Publishers

Publication Date: 27 February 2026

ISSN: 18722083

DOI: 10.2174/0118722083419407251202120006

Scopus: View on Scopus

PubMed: 41764612

Document Type: Article


Authors and Affiliations

Elashry M.A., Surgery Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Samir S., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Elrefaiy M., Gastroenterology and Hepatology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Hammam O., Pathology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Abu Taleb H., Environment Research Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Ossama Y., Pathology Department, October 6 University, Egypt; Elmeligy H.A., Surgery Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt


Abstract

Introduction: Ranked as the third most diagnosed cancer globally, colorectal cancer (CRC) is the seventh most prevalent cancer in Egypt. This study aimed to assess the levels of taurine (Tau), carcinoembryonic antigen (CEA), and p53 upregulated modulator of apoptosis (PUMA) in CRC patients. Methods: We conducted a pilot study involving 70 patients with CRC. Serum Tau was measured using ELISA, CEA was evaluated by immunohistochemistry (IHC), and PUMA expression was assessed using quantitative real-time PCR (qPCR). All measurements were taken before surgery, one week after surgery, and one month later. Results: Tau levels were significantly lower in adenocarcinoma groups (G1, G2, and G3) and in the malignant metastatic group compared with the control and inflammatory groups (p < 0.001). Tau levels increased in G1, G2, and G3 patients one week and one month after surgery. PUMA expression after surgery was higher than before surgery in G1, G2, and G3 adenocarcinoma groups, while it was absent in the metastatic group. The specificity of the Tau test before surgery, one week after, and one month after was 53.33%, 76.92%, and 46.67%, respectively. The specificity of the PUMA test was 76.92% before surgery and 71.43% after surgery. CEA levels were significantly higher in adenocarcinoma (G1 and G2) compared with control and inflammatory groups, whereas CEA staining intensity was significantly decreased in adenocarcinoma (G1 and G2) compared with these groups (p < 0.001). Discussion: PUMA expression tends to be lower in advanced CRC stages and increases after surgery, supporting its potential role in tumor suppression and prognosis. Taurine shows variable levels among CRC patients and may aid in non-invasive cancer staging; its lower serum levels are associated with more advanced disease, and levels rise following surgical removal of the tumor. Conclusion: This study highlights PUMA as a potential prognostic indicator for CRC. Tau levels may also hold diagnostic value and could contribute to the development of non-invasive screening methods for early CRC detection, particularly within the Egyptian population, which remains underrepresented in current research. Such results may be used to stimulate future patents on CRC biomarker-based diagnostics and customized treatment methods. 2026, Bentham Science Publishers


Keywords

Colorectal cancer; ELISA; IHC; PUMA; qPCR; taurine; Antigens; Body fluids; Cell death; Diagnosis; Diseases; Surgery; Cancer patients; Carcinoembryonic antigen; Diagnostics and prognostics; Immunohistochemistry; P53 up-regulated modulator of apoptosis; Pilot studies; Tumors


Citation Information

Scopus Citations: 0


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Multifunctional polycaprolactone-based composite fibers with icariin and glutathione for effective repair of critical-sized bone defects

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region